You are here: Industry Insights > Diabetes

News List

ADA: Teplizumab Can Delay T1DM Progression in Those at Risk drugs
June 14, 2019
Teplizumab Can Delay T1DM Progression in Those at Risk.
Type 1 Diabetes Might Affect Young Kids' Brain Development drugs
June 14, 2019
Type 1 Diabetes Might Affect Young Kids' Brain Development.
Lilly's Tirzepatide Demonstrates Benefits in Data Presented at the American Diabetes Association's? 79?? Scientific Sessions drugs
June 13, 2019
Lilly's Tirzepatide Demonstrates Benefits in Data Presented at the American Diabetes Association's? 79?? Scientific Sessions.
Vitamin D Supplements Don't Prevent Type 2 Diabetes: Study drugs
June 11, 2019
Vitamin D Supplements Don't Prevent Type 2 Diabetes.
Investigational Drug, Teplizumab, May Help Delay Onset of Type 1 Diabetes drugs
June 11, 2019
Investigational Drug, Teplizumab, May Help Delay Onset of Type 1 Diabetes.
What and How You Eat Affects Your Odds for Type 2 Diabetes drugs
June 10, 2019
What and How You Eat Affects Your Odds for Type 2 Diabetes.
Recent Plateauing Seen in Prevalence of Diagnosed Diabetes drugs
May 30, 2019
Recent Plateauing Seen in Prevalence of Diagnosed Diabetes.
The global GLP-1R agonist market rapidly expands PharmaSources/1℃
May 29, 2019
According to my statistical data, the global diabetes market size was around USD40 billion during 2008-2018, wherein, insulin products accounted for about 50%.
Polyethylene Glycol Loxenatide! The First Chinese-produced Long-acting GLP-1R Agonist PharmaSources/1℃
May 29, 2019
The blockbuster diabetes product: long-acting GLP-1 receptor agonist polyethylene glycol loxenatide (trade name: Fulaimei) of Hansoh Pharmaceutical has been marketed on May 7, 2019
New Gene Variants for Type 2 Diabetes Found drugs
May 24, 2019
New Gene Variants for Type 2 Diabetes Found.